CSGO: MOUZ, ENCE win berths in CS Asia Championships semis

Date:

Share post:


MOUZ and ENCE advanced to the semifinals of the $500,000 CS Asia Championships with victories Saturday in Shanghai, China.

In its quarterfinal contest, MOUZ topped Lynn Vision Gaming 13-3 on Overpass and 13-7 on Inferno. Jimi “Jimpphat” Salo of Finland led the way for MOUZ with 41 kills against 17 deaths for a +24 advantage.

In Saturday’s other quarterfinal, ENCE eliminated Ninjas in Pyjamas 2-1. ENCE jumped out to the lead by winning 13-8 on Nuke, but NiP came back to tie by taking Overpass by the same score. ENCE finished the match with a 13-6 triumph on Ancient.

Guy “Nertz” Iluz of Israel had 47 kills and 35 deaths to lead ENCE.

On Sunday, Mouz will face Astralis and ENCE will play FaZe Clan in the semifinals. The grand final will follow in the best-of-three contests.

The winner of the grand final will earn $250,000, with the runner-up taking home $100,000.

CS Asia Championships 2023 prize pool:
1. $250,000 — TBD
2. $100,000 — TBD
3-4. $50,000 — TBD, TBD
5-6. $16,500 – Lynn Vision Gaming, Ninjas in Pyjamas
7-8. $8,500 — TYLOO, Wings Up Gaming

–Field Level Media

spot_img

Related articles

CSGO: Fnatic add casle, Independent to CS2 coaching staff

Peter "casle" Ardenskjold and Miks "Independent" Silins were named the head coach and assistant coach, respectively, of the...

MADDEN: Madden Bowl lands musical stars Chris Stapleton, Jelly Roll, Shaboozey

Kendrick Lamar will headline the halftime show of Super Bowl LIX, but two days prior to the big...

CSGO: Team Vitality president: ropz ‘fits perfectly into our vision’

Team Vitality signed former FaZe Clan player Robin "ropz" Kool to their Counter-Strike 2 roster on Friday. Fellow rifler...

MADDEN: CleffTheGod earns first Madden title at Zero Chill

Dwayne "CleffTheGod" Wood pulled out a 37-34 overtime win over "VELUSJONES" to capture the Madden Zero Chill Challenge...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.